Trellus Health Share Discussion Threads

[mirandaj] 26/5/2021 15:43

Backing for Trellus

[wan] 26/5/2021 08:44

Seeing as Barclays are making no attempt to recognise or notify investors of the shares that they are due, I have printed that announcement off and put it in my Barclay SIPP and ISA files.

[wan] 26/5/2021 08:40

Aspringo...Eventually in 12 months time. In other words, your entitlement shares (in specie shares) are currently held on trust and will be released 12 months after admission of Trellus onto AIM.

Barclays in their infinite wisdom, has decided to not even show that investors are due these shares (by way of a note on the account). And in another show of poor service, nor did Barclays notify investors of the restricted offer (which nominees were guided to do).

Anyway, FYI - Excerpt from the EKF Announcement -

On 11 December 2020 the board of EKF (the “Board”) convened and declared a dividend in specie of shares in Trellus to trustees, to be held on trust for the Company's shareholders (the "Dividend"). EKF’s investment in Trellus comprises 27,999,999 A Shares of £0.0001 each and 1 golden share of £0.0001 (the "Golden Share"). The Golden Share is the voting share in the capital of Trellus and will be retained by the Company. The Company's shareholders on the register as at close of business on 17 December 2020 ("Relevant EKF Shareholders") will receive one A Share (each a "Dividend Share") for every 16.25 ordinary share held in the Company.

Relevant EKF Shareholders will become the beneficial owners of their respective Dividend Shares upon completion of the transfer of the Dividend Shares to Broadway Nominees Limited (“Broadway”), at which time an ‘omnibus’ share certificate in respect of the Dividend Shares will be issued and held by Broadway, to be held on trust by it on behalf of the Relevant EKF Shareholders for a period of:

365 days following admission to trading on AIM (or another recognised stock exchange) of the issued share capital of Trellus
Full announcement -

[cambridgedon] 26/5/2021 08:08

Good question!
CD

[aspringo] 26/5/2021 07:42

Just a quick question for some of you guys that are with barclays.
I have ekf shares but cannot take up the offer to buy trellis.
Will those I qualify for as aong term holder show up in my account, though restricted, or will I need to contact barclays.
Apologies if a poor question.
Thank you.

[bscuit] 25/5/2021 10:12

I applied for 20,000 but the ISA (CSD temporary home for the A shares but they will not be able to stay there) shows subscription rights for 200,000, which I think must be CSD typo as there is no basis for allocation.

[pugugly] 25/5/2021 06:54

Just for the record to save digging back to the announcement

"The expected admission date for Trellus Shares to commence trading on AIM is 8:00 a.m. on Friday, 28 May 2021. Shareholders will be informed their restricted allocation just before trading on Friday, 28 May 2021. "

Surprised that the gap between closing on Monday 24th and Friday for commencement -

[cgequityinvest] 24/5/2021 16:46

Given the demand indicated i think we will be lucky to get 20%. The alternative is they cap the figure for all applicants notwithstanding what they applied for, say 1500 shares for every applicant (or lower if their application was below this).

I am certainly expecting to be refunded most of my money - we will know soon.

[retirementfund] 24/5/2021 11:59

What are we all expecting as a scale back allocation only had 1000 specie shares

[martinikenny] 24/5/2021 08:52

With Interactive Investors ISA, I have a number of shares at 40p - not as 60p ( adobbing). I got 2.5 share for every £1 requested. This 'full' allocation is displayed at 0p. I guess it will get scaled back when the real numbers are in on Friday morning. (Quote from RNS - The expected admission date for Trellus Shares to commence trading on AIM is 8:00 a.m. on Friday, 28 May 2021. Shareholders will be informed their restricted allocation just before trading on Friday, 28 May 2021. )

[adobbing] 24/5/2021 07:55

Just checked my Interactive Investors ISA and it now shows 2500 Tellus health restricted offer.
Value shows as £0 and price shows as 0p
As I requested £1000 worth, I’m guessing that at 40p I got the full amount I subscribed for.

Updated after checking my account, I must have only gone for £1000 not £1500!

[welshborderer] 22/5/2021 11:14

Adding my thanks Wan (aka Speedy Gonzales)

[cambridgedon] 22/5/2021 08:43

Excellent. Thanks Wan.
Cd

[capitalist] 22/5/2021 06:16

Thanks wan

[wan] 22/5/2021 05:39

Initial Trellus Health thread, I will edit and populate the header further in due course.

[wan] 22/5/2021 05:34

LONDON, UK. AND NEW YORK, U.S. (20 May 2021). Trellus Health plc (AIM: TRLS), which is commercialising a scientifically validated, resilience-based, connected digital health solution for chronic condition management, is pleased to announce that it is today launching the Restricted Offer element of its Fundraising, having received very strong levels of support for the placing and subscription.

Key Fundraising Statistics:

Total Fundraising Size: £28.5 million

Issue Price per Trellus Share: 40 pence

Number of Ordinary Shares in issue at Admission 161,475,000

Market capitalisation at the Issue Price: circa £64.6 million

Trellus Health - Precision Medicine Meets Resilience-Driven Care
Because everyone living with a chronic condition should have hope and thrive.

Coordinating and Connecting Multidisciplinary Care for Complex Chronic Conditions, Starting with IBD

Trellus coordinates expert whole-person care rooted in resilience for people living with complex chronic conditions, improving outcomes and lowering overall healthcare costs and is transforming the way chronic conditions are treated.


The Company will utilise a team of licensed, multidisciplinary healthcare providers to deliver and coordinate care remotely via telehealth.

Technology platform and intellectual property:
The Company’s connected health solution will be enabled through an integrated suite of technology and IP to enable scalable remote access for the Company’s care team, patients, and their health care providers.

The primary components of the Company’s connected health solution include:
*TrellusElevateTM platform
*HIPAA-Compliant telehealth platform
*GRITTTM resilience assessment and personalised care plans
*Quad4XTM risk stratifier
*Digital education and behavioural tools
*Remote patient monitoring of symptoms, biomarkers, behaviours

The Company expects to generate initial revenue in 2021 through demonstration projects with healthcare payers in the New York City metropolitan area. The Company’s digitally-delivered solution and value-based recurring revenue model will present attractive unit economics, high margins, cash generation, and forward visibility as a function of the number of engaged patients in the program.

Informative interview/Q&A -
Trellus Health IPO - Management Q&A


Healthtech in the fast lane: What is fueling investor excitement?
As adoption of healthcare technology accelerates, it’s a good time for healthcare companies to consider investing in digital among nine potential “value pools.”